Assystem's share price has risen by almost 3%, with Invest Securities reiterating its 'buy' recommendation and raising its target price from 44 to 50 euros, following a clear outperformance of the stock in 2022, in the wake of the nuclear revival.

While it believes that 'this paradigm shift will take time to materialize in results', it believes that Assystem is enjoying resilient momentum in the meantime, and sees the disposal of shares in Expleo and Framatome as catalysts for 2023/24.

Copyright (c) 2023 CercleFinance.com. All rights reserved.